CurrentEndo
Get Weekly

Topic · page 9 of 16

Endocrine oncology

Thyroid cancer including radioiodine treatment and treatment of advanced disease, adrenocortical carcinoma, metastatic pheochromocytoma and paraganglioma, multiple endocrine neoplasia, neuroendocrine tumors, functioning or not

Briefs 321–360 of 606 placed here, newest publication first

Briefs in Endocrine oncology

Newest publication first

  1. Thyroid

    Clinicopathological Features of CCDC6-RET and NCOA4-RET Fusions in Thyroid Cancer: A Single-Center Retrospective Cohort Study in a Chinese Population

    Cohort study

  2. J Clin Endocrinol Metab

    Preoperative Serum Lipids as Novel Predictors of Survival in 3575 Patients With Papillary Thyroid Cancer

    Cohort study

  3. Endocr Pract

    Defining the Functional Sensitivity for the Siemens Atellica Calcitonin Assay: Insight From a Single-Center Study

    Diagnostic or prognostic study

  4. Endocr Pract

    Use of Natural Language Processing to Extract and Classify Papillary Thyroid Cancer Features From Surgical Pathology Reports

    Diagnostic or prognostic study

  5. Horm Res Paediatr

    Two Decades of Thyroid Nodule Cytology in Children: Malignancy Risk Assessment at a Tertiary Care Center

    Cross-sectional study

  6. J Clin Endocrinol Metab

    BRAF-induced EHF Expression Affects TERT in Aggressive Papillary Thyroid Cancer

    Mechanistic study

  7. J Clin Endocrinol Metab

    Molecular Profiling of Low-Risk Papillary Thyroid Carcinoma (mPTC) on Active Surveillance

    Cohort study

  8. Horm Res Paediatr

    Pubertal, Auxological, and Adult Height Outcomes in Children Treated for Adrenocortical Tumors: Half a Century Experience

    Cohort study

  9. J Clin Endocrinol Metab

    Impact of Reclassification of Oncocytic and Follicular Thyroid Carcinoma by the 2022 WHO Classification

    Cohort study

  10. J Clin Endocrinol Metab

    Pediatric Papillary Thyroid Carcinoma: Outcomes After Surgery Without Adjuvant Radioactive Iodine

    Cohort study

  11. Eur Thyroid J

    Digoxin treatment does not reinduce radioiodine uptake in radioiodine refractory non-medullary thyroid carcinoma

    Cohort study

  12. J Clin Endocrinol Metab

    Data-driven Thyroglobulin Cutoffs for Low- and Intermediate-risk Thyroid Cancer Follow-up: ITCO Real-world Analysis

    Cohort study

  13. J Clin Endocrinol Metab

    Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid Cancer

    Secondary analysis

  14. J Clin Endocrinol Metab

    Association of Free Thyroxine With Progression-Free Survival in Intermediate and High-Risk Differentiated Thyroid Cancer

    Cohort study

  15. Thyroid

    FGFR Alterations in Thyroid Carcinoma: A Novel Class of Primary Drivers with Significant Therapeutic Implications and Secondary Molecular Events Potentially Mediating Resistance in Thyroid Malignancy

    Cohort study

  16. Clin Endocrinol (Oxf)

    Trends in papillary thyroid cancer mortality in Denmark according to stage and education

    Cohort study

  17. Eur Thyroid J

    Low-invasive somatic oncogenes and lymph node metastasis in pediatric papillary thyroid cancer: implications for prophylactic central neck dissection

    Cohort study

  18. J Clin Endocrinol Metab

    The Association Between Thyroid Differentiation Score and Survival Outcomes in Papillary Thyroid Carcinoma

    Cohort study

  19. Eur J Endocrinol

    Prevalence of drugs used for chronic conditions after diagnosis of thyroid cancer: a register-based cohort study

    Cohort study

  20. Eur Thyroid J

    Hand–foot syndrome in sorafenib and lenvatinib treatment for advanced thyroid cancer

    Cohort study

  21. Thyroid

    The Multi-Institutional Medullary Thyroid Cancer Collaborative Registry: Can a Rare Tumor Registry Accurately Represent the Real-World Patient Population?

    Cross-sectional study

  22. Eur Thyroid J

    Incidentally vs non-incidentally diagnosed papillary thyroid carcinoma: are there differences?

    Cohort study

  23. J Clin Endocrinol Metab

    A Comparative Genomic Analysis of Parathyroid Adenomas and Carcinomas Harboring Heterozygous Germline CDC73 Mutations

    Mechanistic study

  24. Thyroid

    Revisiting the Relationship Between Tumor Size and Risk in Well-Differentiated Thyroid Cancer

    Cohort study

  25. J Clin Endocrinol Metab

    Second Primary Differentiated Thyroid Carcinoma in Adult Cancer Survivors: A SEER Database Analysis

    Cohort study

  26. Clin Endocrinol (Oxf)

    Tracking dynamic evolution of low‐ and intermediate‐risk differentiated thyroid cancer: Identification of individuals at risk of recurrence

    Cohort study

  27. Thyroid

    The Association between Lymphocytic Thyroiditis and Papillary Thyroid Cancer Harboring Mutant BRAF : A Systematic Review and Meta-Analysis

    Meta-analysis

  28. Eur Thyroid J

    The role of [18F]F-DOPA PET/CT in diagnostic and prognostic assessment of medullary thyroid cancer: a 15-year experience with 109 patients

    Diagnostic or prognostic study

  29. Thyroid

    Characterization of Immune Infiltrate Along the Leading Edge of Differentiated Thyroid Cancer

    Mechanistic study

  30. Thyroid

    Tumor Growth Kinetics Based on Initial Tumor Volume Doubling Time in Active Surveillance of Low-Risk Papillary Thyroid Carcinoma

    Cohort study

  31. J Clin Endocrinol Metab

    Improving the Risk Prediction of the 2015 ATA Recurrence Risk Stratification in Papillary Thyroid Cancer

    Cohort study

  32. Diabetes Obes Metab

    The interaction effect between BMI , diabetes and age at diabetes onset on the risk of thyroid cancer: A population‐based cohort study in Shanghai, China

    Cohort study

  33. J Clin Endocrinol Metab

    Efficacy and Safety of Multikinase Inhibitors for Patients With Refractory Thyroid Cancer: Systematic Review and Network Meta-Analysis

    Meta-analysis

  34. Thyroid

    Survival Prognostication in Patients with Differentiated Thyroid Cancer and Distant Metastases: A SEER Population-Based Study

    Cohort study

  35. J Clin Endocrinol Metab

    A Phase I/II Trial of Sapanisertib in Advanced Anaplastic and Radioiodine Refractory Differentiated Thyroid Carcinoma

    Cohort study

  36. J Clin Endocrinol Metab

    Whole-exome Sequencing of Atypical Parathyroid Tumors Detects Novel and Common Genes Linked to Parathyroid Tumorigenesis

    Research article

  37. Eur J Endocrinol

    Targeted Next Generation Sequencing molecular profiling and its clinical application in adrenocortical cancer

    Cohort study

  38. Eur J Endocrinol

    Assessment of prognostic factors in pediatric adrenocortical tumors: the modified pediatric S-GRAS score in an international multicenter cohort—a work from the ENSAT-PACT working group

    Cohort study

  39. Thyroid

    Improved Diagnostic Accuracy of Thyroid Fine-Needle Aspiration Cytology with Artificial Intelligence Technology

    Diagnostic or prognostic study

  40. Clin Endocrinol (Oxf)

    Comprehensive genomic profiling from C‐CAT database unveiled over 80% presence of oncogenic drivers in anaplastic thyroid carcinoma including BRAF, RAS family, NF1, and FGFR1

    Cohort study

All 606 Briefs in ExploreShowing Briefs 321–360 of 606, newest first